참고문헌
- Lee HJ, Kim J, Chang SA, Kim YJ, Kim HK, Lee SC. Major clinical issues in hypertrophic cardiomyopathy. Korean Circ J 2022;52:563-75.
- Liu PP, Mason JW. Advances in the understanding of myocarditis. Circulation 2001;104:1076-82.
- Cho JY, Cho DH, Youn JC, et al. Korean Society of Heart Failure guidelines for the management of heart failure: definition and diagnosis. Korean Circ J 2023;53:195-216.
- Jung Y, Kim J, Jang H, Kim G, Kwon YW. Strategy of patient-specific therapeutics in cardiovascular disease through single-cell RNA sequencing. Korean Circ J 2023;53:1-16.
- Raghow R. An 'Omics' perspective on cardiomyopathies and heart failure. Trends Mol Med 2016;22:813-27.
- Michelhaugh SA, Januzzi JL Jr. Finding a needle in a haystack: proteomics in heart failure. JACC Basic Transl Sci 2020;5:1043-53.
- Dupree EJ, Jayathirtha M, Yorkey H, Mihasan M, Petre BA, Darie CC. A critical review of bottom-up proteomics: the good, the bad, and the future of this field. Proteomes 2020;8:14.
- Shimada YJ, Raita Y, Liang LW, et al. Comprehensive proteomics profiling reveals circulating biomarkers of hypertrophic cardiomyopathy. Circ Heart Fail 2021;14:e007849.
- Shimada YJ, Raita Y, Liang LW, et al. Prediction of major adverse cardiovascular events in patients with hypertrophic cardiomyopathy using proteomics profiling. Circ Genom Precis Med 2022;15:e003546.
- Tayal U, Verdonschot JA, Hazebroek MR, et al. Precision phenotyping of dilated cardiomyopathy using multidimensional data. J Am Coll Cardiol 2022;79:2219-32.
- Lee S, Jang DG, Kyoung YJ, et al. Proteome-wide characterization and pathophysiology correlation in non-ischemic cardiomyopathies. Korean Circ J 2024;54:468-81.